These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26339784)

  • 21. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus.
    Okada A; Miura T; Takeuchi H
    Biochemistry; 2001 May; 40(20):6053-60. PubMed ID: 11352741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ab initio study of hydrogen-bond formation between aliphatic and phenolic hydroxy groups and selected amino acid side chains.
    Nagy PI; Erhardt PW
    J Phys Chem A; 2008 May; 112(18):4342-54. PubMed ID: 18373368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase.
    Birch L; Murray CW; Hartshorn MJ; Tickle IJ; Verdonk ML
    J Comput Aided Mol Des; 2002 Dec; 16(12):855-69. PubMed ID: 12825619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase.
    Kati WM; Montgomery D; Maring C; Stoll VS; Giranda V; Chen X; Laver WG; Kohlbrenner W; Norbeck DW
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2563-70. PubMed ID: 11502530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of water coordination on competition between π and non-π cation binding sites in aromatic amino acids: L-phenylalanine, L-tyrosine, and L-tryptophan Li+, Na +, and K+ complexes.
    Remko M; Šoralová S
    J Biol Inorg Chem; 2012 Apr; 17(4):621-30. PubMed ID: 22327774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-dependent conformation, dynamics, and aromatic interaction of the gating tryptophan residue of the influenza M2 proton channel from solid-state NMR.
    Williams JK; Zhang Y; Schmidt-Rohr K; Hong M
    Biophys J; 2013 Apr; 104(8):1698-708. PubMed ID: 23601317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of the histidine and tryptophan side chains in the M2 proton channel from influenza A virus.
    Takeuchi H; Okada A; Miura T
    FEBS Lett; 2003 Sep; 552(1):35-8. PubMed ID: 12972149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of drug resistance in A/H1N1 virus.
    Vergara-Jaque A; Poblete H; Lee EH; Schulten K; González-Nilo F; Chipot C
    J Chem Inf Model; 2012 Oct; 52(10):2650-6. PubMed ID: 22978683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus.
    Salom D; Hill BR; Lear JD; DeGrado WF
    Biochemistry; 2000 Nov; 39(46):14160-70. PubMed ID: 11087364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).
    Hitaoka S; Matoba H; Harada M; Yoshida T; Tsuji D; Hirokawa T; Itoh K; Chuman H
    J Chem Inf Model; 2011 Oct; 51(10):2706-16. PubMed ID: 21870866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal cation dependence of interactions with amino acids: bond energies of Rb+ and Cs+ to Met, Phe, Tyr, and Trp.
    Armentrout PB; Yang B; Rodgers MT
    J Phys Chem B; 2013 Apr; 117(14):3771-81. PubMed ID: 23514190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.
    Singh KhD; Kirubakaran P; Nagamani S; Karthikeyan M
    Int J Comput Biol Drug Des; 2015; 8(1):1-18. PubMed ID: 25869316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
    Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
    Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and theoretical studies of sodium cation interactions with the acidic amino acids and their amide derivatives.
    Heaton AL; Moision RM; Armentrout PB
    J Phys Chem A; 2008 Apr; 112(15):3319-27. PubMed ID: 18355061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.
    Yang Z; Yang G; Zhou L
    J Comput Aided Mol Des; 2013 Nov; 27(11):935-50. PubMed ID: 24218291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K.
    Tran-To Su C; Ouyang X; Zheng J; Kwoh CK
    BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S7. PubMed ID: 24564719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.